|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2019
As of Sep 30, 2019
|
Q2 FY2019
As of Jun 30, 2019
|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | ||||||||||||||||||||
| Grant receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accounts payable - related party | ||||||||||||||||||||
| Deferred grant income | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Mezzanine Equity | ||||||||||||||||||||
| Total Mezzanine Equity | ||||||||||||||||||||
| Common stock: $0.01 par value; 82,000,000 shares authorized; 73,644,797, 73,644,797 and 40,844,797 shares issued, respectively | ||||||||||||||||||||
| Total common stock: $0.01 par value; 82,000,000 shares authorized; 73,644,797, 73,644,797 and 40,844,797 shares issued, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Treasury stock at cost: 714,750 shares | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders' deficit attributed to alpha-En Corporation stockholders | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| Total Liabilities, Mezzanine Equity and Stockholders' Deficit and Temporary Equity | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
Loading...